Vanderbilt Eye Institute Archives

Smiling young African girl with long curly hair wearing glasses while standing alone against a gray background

VUMC participates in national study to test eye drops for nearsightedness in children

Aug. 1, 2023—A multi-institutional study found that low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

Paul Sternberg Jr., MD, center, with C. Wright Pinson, MBA, MD, left, and Jeff Balser, MD, PhD, at a recent celebration honoring Sternberg’s years of service to VUMC.

Celebration honors Paul Sternberg’s decades of service

Jun. 22, 2023—Paul Sternberg Jr., MD, was celebrated last week at a retirement ceremony honoring his 20 years of service to Vanderbilt University Medical Center as chair of the Department of Ophthalmology and Visual Sciences and founding director of the Vanderbilt Eye Institute.

Wallace named as VUMC’s New Chair of Ophthalmology and Visual Sciences

May. 4, 2023—David Wallace, MD, MPH, has been named as the new chair of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute.

Lori Ann Kehler, OD, gives a low vision exam to patient Mary Elizabeth Parker at the Vanderbilt Eye Institute.

Low vision initiative for children lands new funding

Oct. 27, 2022—Vanderbilt's Project PAVE has received funding from the Tennessee Department of Intellectual and Developmental Disabilities to continue the program that has provided low-vision evaluations for more than 2,150 school-age children in Tennessee since 1993.

Opening a window to glaucoma

Oct. 10, 2022—A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

The International Retinal Research Foundation Board’s Sandra Blackwood poses with Vanderbilt’s Paul Sternberg Jr., MD, left, and David Calkins, PhD.

Major commitment bolsters Vanderbilt’s retinal vision research efforts

Sep. 22, 2022—A $10 million gift from the International Retinal Research Foundation will establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.

Calkins lands national award for research on blinding eye diseases

Sep. 8, 2022—Vanderbilt's David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.

Vanderbilt experts offer tips for good eye health

Aug. 26, 2022—Vanderbilt experts offer tips for good vision health during Eye Health and Safety Awareness Month.

Sternberg to step down after two decades at Vanderbilt

Aug. 16, 2022—Paul Sternberg Jr., MD, is stepping down from his role as chair of the Department of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute, effective June 30, 2023.

Mitochondria and retinal degeneration

Aug. 15, 2022—Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.

New program helps low-vision patients more safely navigate their home environments

Jul. 14, 2022— by Nancy Humphrey Thomas Scott, who is legally blind and lives alone, had trouble getting around his home. Navigating stairs was difficult, and the lighting in his home wasn’t ideal. To make matters worse, the 73-year-old southeast Nashville man doesn’t have the best balance. But thanks to a collaborative effort and pilot program between...

HOSA competition

Jul. 7, 2022—Nashville was the host city for the recent Health Occupations Students of America leadership conference and the Vanderbilt Eye Institute was invited to host a competition.